David Tepper Appaloosa LP
David Tepper, founder of Appaloosa Management, is a billionaire hedge fund manager renowned for his expertise in distressed debt investing and contrarian bets. He is known for high-risk, high-reward strategies that have generated significant returns, such as investing in struggling banks during the 2008 financial crisis. His investment philosophy emphasizes deep value analysis, understanding market psychology, and making high-conviction decisions, often going against prevailing sentiment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$630M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$202M |
| 3 |
Pfizer
PFE
|
+$155M |
| 4 |
PNC Financial Services
PNC
|
+$139M |
| 5 |
Viatris
VTRS
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synchrony
SYF
|
+$117M |
| 2 |
Whirlpool
WHR
|
+$98M |
| 3 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$90.2M |
| 4 |
Bank of America
BAC
|
+$64.7M |
| 5 |
Apple
AAPL
|
+$39.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.67% |
| 2 | Energy | 16.45% |
| 3 | Financials | 12.71% |
| 4 | Communication Services | 11.06% |
| 5 | Industrials | 6.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $895M | 15.87% |
4,261,406
+3,043,097
| +250% | +$630M |
|
|
ETP
2
DELISTED
Energy Transfer Partners L.p.
ETP
| $428M | 7.59% |
11,961,842
+346,185
| +3% | +$12.3M |
|
3
Alphabet (Google) Class C
GOOG
$4.19T
| $373M | 6.61% |
9,660,000
+220,000
| +2% | +$8.57M |
|
|
WPZ
4
DELISTED
Williams Partners L.P.
WPZ
| $361M | 6.4% |
9,487,301
+220,437
| +2% | +$7.92M |
|
5
Meta Platforms (Facebook)
META
$1.53T
| $251M | 4.45% |
2,182,350
+697,742
| +47% | +$85.7M |
|
|
6
PNC Financial Services
PNC
$101B
| $228M | 4.05% |
1,950,973
+1,338,528
| +219% | +$139M |
|
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
| $224M | 3.96% |
1,000,000
-1,500,000
| -60% | -$328M |
|
8
Allstate
ALL
$66.3B
| $192M | 3.41% |
2,594,834
-524,989
| -17% | -$37M |
|
|
9
Teva Pharmaceuticals
TEVA
$42.5B
| $183M | 3.25% |
+5,053,000
| New | +$202M |
|
|
10
Pfizer
PFE
$152B
| $156M | 2.77% |
+5,069,740
| New | +$155M |
|
11
Owens Corning
OC
$12.6B
| $140M | 2.48% |
2,716,544
-235,463
| -8% | -$12.2M |
|
12
Mohawk Industries
MHK
$9.26B
| $126M | 2.24% |
632,164
+54,113
| +9% | +$10.6M |
|
|
13
Viatris
VTRS
$18.7B
| $125M | 2.22% |
+3,275,000
| New | +$122M |
|
|
AY
14
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $113M | 2% |
5,820,326
-186,145
| -3% | -$3.4M |
|
|
TERP
15
DELISTED
TerraForm Power, Inc
TERP
| $112M | 1.98% |
8,708,708
| – | – |
|
16
Huntsman Corp
HUN
$1.83B
| $109M | 1.93% |
5,715,053
-630,265
| -10% | -$11.4M |
|
17
Regions Financial
RF
$26.9B
| $105M | 1.87% |
+7,340,137
| New | +$90.7M |
|
|
18
Whirlpool
WHR
$2.84B
| $103M | 1.83% |
566,936
-591,858
| -51% | -$98M |
|
19
Citizens Financial Group
CFG
$30.7B
| $101M | 1.79% |
2,829,750
+249,613
| +10% | +$7.56M |
|
20
Qualcomm
QCOM
$171B
| $91.3M | 1.62% |
1,400,000
+500,000
| +56% | +$33.6M |
|
21
HCA Healthcare
HCA
$89.1B
| $84.8M | 1.5% |
1,145,250
-91,690
| -7% | -$6.87M |
|
22
Kinder Morgan
KMI
$70.1B
| $84.1M | 1.49% |
4,062,996
+412,996
| +11% | +$8.73M |
|
|
SGI
23
Somnigroup International
SGI
$13.7B
| $79.2M | 1.4% |
4,640,796
-108,592
| -2% | -$1.62M |
|
|
CMA
24
DELISTED
Comerica
CMA
| $78.5M | 1.39% |
+1,151,993
| New | +$67.5M |
|
25
Western Digital
WDC
$151B
| $76.1M | 1.35% |
1,481,760
-39,690
| -3% | -$1.83M |
|
Similar funds
David Tepper's Q4 2016 Portfolio in Review
As of Q4 2016, David Tepper held 63 positions worth $5.64B, up 28% from $4.4B the previous quarter. Its ten largest holdings account for 58% of the portfolio.
David Tepper deployed $1.13B of net new capital in Q4 2016, opening 21 new positions and adding to 11 existing holdings. Its largest new stake was Teva Pharmaceuticals: 5,053,000 shares worth $183M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 8.5% a quarter earlier, followed by Energy and Financials.
On the sell side, the largest reduction was Whirlpool, an estimated $98M trimmed.
- David Tepper's largest Q4 2016 buy was Teva Pharmaceuticals: 5,053,000 shares worth $183M.
- David Tepper added most to Allergan plc in Q4 2016, an estimated $630M increase.
- David Tepper's biggest Q4 2016 reduction was Whirlpool, cutting an estimated $98M.
- David Tepper fully exited Synchrony in Q4 2016, selling an estimated $117M.
- David Tepper's ten largest holdings make up 58% of its $5.64B portfolio in Q4 2016.
- David Tepper opened 21 new positions and closed 9 in Q4 2016.
- David Tepper's portfolio value rose 28% quarter-over-quarter to $5.64B.
Based on Appaloosa LP's 13F filing for Q4 2016, filed 14 Feb 2017.